Seres Therapeutics Reports Second Quarter Financial Results and Provides Operational Progress Update

Go back to Seres Therapeutics Reports Second Quarter Financial Results and Provides Operational Progress Update
(NASDAQ: MCRB) Delayed: 2.94 +0.01 (0.34%)
Previous Close $2.93    52 Week High $44.51 
Open $2.98    52 Week Low $8.05 
Day High $3.20    P/E N/A 
Day Low $2.91    EPS $0.00 
Volume 100,955